The voltage-gated potassium channel K

Animals Autoimmune Diseases / drug therapy Disease Models, Animal Humans Inflammation / drug therapy Kv1.3 Potassium Channel / antagonists & inhibitors Molecular Targeted Therapy / methods Peptides / chemistry Potassium Channel Blockers / chemistry Venoms / chemistry
Fibrosis Inflammatory bowel disease Neuroinflammation Peptide Therapeutic development Toxin Voltage-gated potassium channel

Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
11 2020
Historique:
received: 15 05 2020
revised: 05 07 2020
accepted: 07 07 2020
pubmed: 13 7 2020
medline: 5 1 2021
entrez: 13 7 2020
Statut: ppublish

Résumé

The voltage-gated potassium channel K

Identifiants

DOI: 10.1016/j.bcp.2020.114146 PMID: 32653588
pubmed: 32653588
pii: S0006-2952(20)30382-8
doi: 10.1016/j.bcp.2020.114146
pii:
doi:

Substances chimiques

Kv1.3 Potassium Channel 0
Peptides 0
Potassium Channel Blockers 0
Venoms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114146

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Gabor Tajti (G)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

Dorothy C C Wai (DCC)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.

Gyorgy Panyi (G)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Electronic address: panyi@med.unideb.hu.

Raymond S Norton (RS)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia; ARC Centre for Fragment-Based Design, Monash University, Parkville, VIC 3052, Australia. Electronic address: ray.norton@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › The voltage-gated potassium channel K
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › The voltage-gated potassium channel K
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › The voltage-gated potassium channel K
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The voltage-gated potassium channel K
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › The voltage-gated potassium channel K
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Protéines de transport membranaire › Canaux ioniques › Canaux potassiques › Canaux potassiques voltage-dépendants › Canaux potassiques de la superfamille Shaker › Canal potassique Kv1.3 › The voltage-gated potassium channel K
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Thérapie moléculaire ciblée › The voltage-gated potassium channel K
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › The voltage-gated potassium channel K
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents cardiovasculaires › Inhibiteurs des canaux potassiques › The voltage-gated potassium channel K
questionsmedicales.fr › Facteurs biologiques › Toxines biologiques › Venins › The voltage-gated potassium channel K